Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: A case-control association study

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Möller, Marlo ^a   Nebel, Almut ^b   van Helden, Paul D ^a   Schreiber, Stefan ^b   Hoal, Eileen G ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FRIZZLED HOMOLOG 5 PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 4; UNCLASSIFIED DRUG; WNT5A PROTEIN;

ADULT; ALLELE; ANALYTIC METHOD; ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FLUORESCENCE ANALYSIS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOMODULATION; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA; TUBERCULOSIS; ADOLESCENT; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY;

ADOLESCENT; ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERFERON-GAMMA; MALE; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, GENETIC; SOUTH AFRICA; TUBERCULOSIS; YOUNG ADULT;

EID: 77953030539     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-154     Document Type: Article

References (88)

1. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 1978, 117:621-624.
2. Jepson A, Fowler A, Banya W, Singh M, Bennett S, Whittle H, Hill AV. Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis a study of twins in West Africa. Infect Immun 2001, 69:3989-3994. 10.1128/IAI.69.6.3989-3994.2001, 98461, 11349068.
3. Kallmann FJ, Reisner D. Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tuberc 1942, 47:549-547.
4. Newport MJ, Goetghebuer T, Weiss HA, Whittle H, Siegrist CA, Marchant A. Genetic regulation of immune responses to vaccines in early life. Genes Immun 2004, 5:122-129. 10.1038/sj.gene.6364051, 14737096.
5. Kimman TG, Janssen R, Hoebee B. Future prospects in respiratory syncytial virus genetics. Future Virology 2006, 1:483-492.
6. Cobat A, Gallant CJ, Simkin L, Black GF, Stanley K, Hughes J, Doherty TM, Hanekom WA, Eley B, Beyers N, Jaïs J, van Helden PD, Abel L, Hoal EG, Alcaïs A, Schurr E. High heritability of anti-mycobacterial immunity in a hyper-endemic area for tuberculosis disease. J Infect Dis 2010, 201:15-19. 10.1086/648611, 19938975.
7. Möller M, de Wit E, Hoal EG. Past, present and future directions in human genetic susceptibility to tuberculosis. FEMS Immunol Med Microbiol 2010, 58:3-26. 10.1111/j.1574-695X.2009.00600.x, 19780822.
8. van Helden PD, Möller M, Babb C, Warren R, Walzl G, Uys P, Hoal E. TB epidemiology and human genetics. Novartis Found Symp 2006, 279:17-31. full_text, 17278383.
9. Leal IS, Smedegard B, Andersen P, Appelberg R. Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation. Immunology 2001, 104:157-161. 10.1046/j.1365-2567.2001.01305.x, 1783293, 11683955.
10. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993, 178:2243-2247. 10.1084/jem.178.6.2243, 2191280, 8245795.
11. Moreira AL, Tsenova L, Murray PJ, Freeman S, Bergtold A, Chiriboga L, Kaplan G. Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity. Microb Pathog 2000, 29:175-185. 10.1006/mpat.2000.0382, 10968949.
12. Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, Robertson S, Wallis RS, Edmonds K, Okwera A, Mugerwa R, Peters P, Ellner JJ. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 1999, 180:2069-2073. 10.1086/315114, 10558973.
13. Jo EK, Park JK, Dockrell HM. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr Opin Infect Dis 2003, 16:205-210.
14. Ribeiro-Rodrigues R, Resende CT, Johnson JL, Ribeiro F, Palaci M, Sa RT, Maciel EL, Pereira Lima FE, Dettoni V, Toossi Z, Boom WH, Dietze R, Ellner JJ, Hirsch CS. Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. Clin Diagn Lab Immunol 2002, 9:818-823. 120011, 12093679.
15. Lin PL, Rodgers M, Smith L, Bigbee M, Myers A, Bigbee C, Chiosea I, Capuano SV, Fuhrman C, Klein E, Flynn J. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect Immun 2009, 77:4631-4642. 10.1128/IAI.00592-09, 2747916, 19620341.
16. Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, Eguale T, Ravn P, Andersen P. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 2002, 40:704-706. 10.1128/JCM.40.2.704-706.2002, 153355, 11826002.
17. Winek J, Rowinska-Zakrzewska E, Demkow U, Szopinski J, Szolkowska M, Filewska M, Jagodzinski J, Roszkowski-Sliz K. Interferon gamma production in the course of Mycobacterium tuberculosis infection. J Physiol Pharmacol 2008, 59(Suppl 6):751-759.
18. Park SK, Cho S, Lee IH, Jeon DS, Hong SH, Smego RA, Cho SN. Subcutaneously administered interferon-gamma for the treatment of multidrug-resistant pulmonary tuberculosis. Int J Infect Dis 2007, 11:434-440. 10.1016/j.ijid.2006.12.004, 17321178.
19. Roberts T, Beyers N, Aguirre A, Walzl G. Immunosuppression during Active Tuberculosis Is Characterized by Decreased Interferon-gamma Production and CD25 Expression with Elevated Forkhead Box P3, Transforming Growth Factor-beta, and Interleukin-4 mRNA Levels. J Infect Dis 2007, 195:870-878. 10.1086/511277, 17299718.
20. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001, 19:93-129. 10.1146/annurev.immunol.19.1.93, 11244032.
21. Mittrücker HW, Steinhoff U, Kohler A, Krause M, Lazar D, Mex P, Miekley D, Kaufmann SH. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc Natl Acad Sci USA 2007, 104:12434-12439. 10.1073/pnas.0703510104, 1941486, 17640915.
22. Buddle BM, Wedlock DN, Denis M, Skinner MA. Identification of immune response correlates for protection against bovine tuberculosis. Vet Immunol Immunopathol 2005, 108:45-51. 10.1016/j.vetimm.2005.08.002, 16140388.
23. Al-Muhsen S, Casanova JL. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol 2008, 122:1043-1051. 10.1016/j.jaci.2008.10.037, 19084105.
24. Rossouw M, Nel HJ, Cooke GS, van Helden PD, Hoal EG. Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet 2003, 361:1871-1872. 10.1016/S0140-6736(03)13491-5, 12788577.
25. Pacheco AG, Cardoso CC, Moraes MO. IFNG +874T/A, IL10 -1082G/A and TNF -308G/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study. Hum Genet 2008, 123:477-484. 10.1007/s00439-008-0497-5, 18414898.
26. Shibasaki M, Yagi T, Yatsuya H, Okamoto M, Nishikawa M, Baba H, Hashimoto N, Senda K, Kawabe T, Nakashima K, Imaizumi K, Shimokata K, Hasegawa Y. An influence of Interferon-gamma gene polymorphisms on treatment response to tuberculosis in Japanese population. J Infect 2009, 58:467-469. 10.1016/j.jinf.2009.04.002, 19427704.
27. Kritzinger FE, den BS, Verver S, Enarson DA, Lombard CJ, Borgdorff MW, Gie RP, Beyers N. No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Trop Med Int Health 2009, 14:136-142. 10.1111/j.1365-3156.2008.02213.x, 19236665.
28. Incidence Of TB In The Provinces Of South Africa. , http://www.hst.org.za/healthstats/16/data
29. Barreiro LB, Neyrolles O, Babb CL, Tailleux L, Quach H, McElreavey K, Helden PD, Hoal EG, Gicquel B, Quintana-Murci L. Promoter Variation in the DC-SIGN Encoding Gene CD209 Is Associated with Tuberculosis. PLoS Medicine 2006, 3:e20. 10.1371/journal.pmed.0030020, 1324949,1324949, 16379498.
30. Bergholdt R, Ghandil P, Johannesen J, Kristiansen OP, Kockum I, Luthman H, Ronningen KS, Nerup J, Julier C, Pociot F. Genetic and functional evaluation of an interleukin-12 polymorphism (IDDM18) in families with type 1 diabetes. J Med Genet 2004, 41:e39. 10.1136/jmg.2003.010454, 1735731, 15060115.
31. Hampe J, Wollstein A, Lu T, Frevel HJ, Will M, Manaster C, Schreiber S. An integrated system for high throughput TaqMan based SNP genotyping. Bioinformatics (Oxford, England) 2001, 17:654-655. 10.1093/bioinformatics/17.7.654, 11448884.
32. Teuber M, Koch WA, Manaster C, Wachter S, Hampe J, Schreiber S. Improving quality control and workflow management in high-throughput single-nucleotide polymorphism genotyping environments. Journal of the Association for Laboratory Automation 2005, 10:43-47.
33. van Rietschoten JG, Westland R, van den Bogaard R, Nieste-Otter MA, van Veen A, Jonkers RE, van der Pouw Kraan TC, den Hartog MT, Wierenga EA. A novel polymorphic GATA site in the human IL-12Rbeta2 promoter region affects transcriptional activity. Tissue Antigens 2004, 63:538-546. 10.1111/j.0001-2815.2004.00223.x, 15140029.
34. Lee EY, Yim JJ, Lee HS, Lee YJ, Lee EB, Song YW. Dinucleotide repeat polymorphism in intron II of human Toll-like receptor 2 gene and susceptibility to rheumatoid arthritis. Int J Immunogenet 2006, 33:211-215. 10.1111/j.1744-313X.2006.00599.x, 16712654.
35. Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, Sasaki H. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000, 66:187-195. 10.1086/302729, 1288325, 10631150.
36. McGinnis RE, Spielman RS. Insulin gene 5' flanking polymorphism. Length of class 1 alleles in number of repeat units. Diabetes 1995, 44:1296-1302. 10.2337/diabetes.44.11.1296, 7589827.
37. Nicodemus KK, Liu W, Chase GA, Tsai YY, Fallin MD. Comparison of type I error for multiple test corrections in large single-nucleotide polymorphism studies using principal components versus haplotype blocking algorithms. BMC Genet 2005, 6(Suppl 1):S78. 10.1186/1471-2156-6-S1-S78, 1866703, 16451692.
38. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003, 25:115-121. 10.1002/gepi.10252, 12916020.
39. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 2005, 21:263-265. 10.1093/bioinformatics/bth457, 15297300.
40. Luoni G, Verra F, Arca B, Sirima BS, Troye-Blomberg M, Coluzzi M, Kwiatkowski D, Modiano D. Antimalarial antibody levels and IL4 polymorphism in the Fulani of West Africa. Genes Immun 2001, 2:411-414. 10.1038/sj.gene.6363797, 11704810.
41. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, Borish L. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995, 25(Suppl 2):74-78. 10.1111/j.1365-2222.1995.tb00428.x, 8590350.
42. Vidyarani M, Selvaraj P, Prabhu AS, Jawahar MS, Adhilakshmi AR, Narayanan PR. Interferon gamma (IFNgamma) & interleukin-4 (IL-4) gene variants & cytokine levels in pulmonary tuberculosis. Indian J Med Res 2006, 124:403-410.
43. Naslednikova IO, Urazova OI, Voronkova OV, Strelis AK, Novitsky VV, Nikulina EL, Hasanova RR, Kononova TE, Serebryakova VA, Vasileva OA, Suhalentseva NA, Churina EG, Kolosova AE, Fedorovich TV. Allelic polymorphism of cytokine genes during pulmonary tuberculosis. Bull Exp Biol Med 2009, 148:175-180. 10.1007/s10517-009-0674-0, 20027321.
44. Bellamy R. Genetic susceptibility and resistance to tuberculosis. PhD Thesis 1998, University of Oxford, Faculty of Clinical Medicine.
45. Vasiliev AM, Vasilenko RN, Kulikova NL, Andreev SM, Chikileva IO, Puchkova GY, Kosarev IV, Khodyakova AV, Khlebnikov VS, Ptitsyn LR, Shcherbakov GY, Uversky VN, DuBuske LM, Abramov VM. Structural and functional properties of IL-4delta2, an alternative splice variant of human IL-4. J Proteome Res 2003, 2:273-281. 10.1021/pr025586y, 12814267.
46. Demissie A, Abebe M, Aseffa A, Rook G, Fletcher H, Zumla A, Weldingh K, Brock I, Andersen P, Doherty TM. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol 2004, 172:6938-6943.
47. Dheda K, Chang JS, Breen RA, Kim LU, Haddock JA, Huggett JF, Johnson MA, Rook GA, Zumla A. In vivo and in vitro studies of a novel cytokine, interleukin 4delta2, in pulmonary tuberculosis. Am J Respir Crit Care Med 2005, 172:501-508. 10.1164/rccm.200502-278OC, 15901609.
48. Dheda K, Chang JS, Huggett JF, Kim LU, Johnson MA, Zumla A, Rook GA. The stability of mRNA encoding IL-4 is increased in pulmonary tuberculosis, while stability of mRNA encoding the antagonistic splice variant, IL-4delta2, is not. Tuberculosis (Edinb) 2007, 87:237-241. 10.1016/j.tube.2006.11.001, 17196882.
49. Babb C, van der Merwe L, Beyers N, Pheiffer C, Walzl G, Duncan K, van Helden P, Hoal EG. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis 2007, 87:295-302. 10.1016/j.tube.2007.03.001, 17449323.
50. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997, 24:1-8.
51. Rosenwasser LJ, Borish L. Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10). Am J Respir Crit Care Med 1997, 156:S152-S155.
52. Shin HD, Winkler C, Stephens JC, Bream J, Young H, Goedert JJ, O'Brien TR, Vlahov D, Buchbinder S, Giorgi J, Rinaldo C, Donfield S, Willoughby A, O'Brien SJ, Smith MW. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci USA 2000, 97:14467-14472. 10.1073/pnas.97.26.14467, 18942, 11121048.
53. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999, 30:526-530. 10.1002/hep.510300207, 10421663.
54. Delgado JC, Baena A, Thim S, Goldfeld AE. Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis 2002, 186:1463-1468. 10.1086/344891, 12404162.
55. Scola L, Crivello A, Marino V, Gioia V, Serauto A, Candore G, Colonna-Romano G, Caruso C, Lio D. IL-10 and TNF-alpha polymorphisms in a sample of Sicilian patients affected by tuberculosis: implication for ageing and life span expectancy. Mech Ageing Dev 2003, 124:569-572. 10.1016/S0047-6374(03)00038-1, 12714269.
56. Oral HB, Budak F, Uzaslan EK, Basturk B, Bekar A, Akalin H, Ege E, Ener B, Goral G. Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis. Cytokine 2006, 35:143-147. 10.1016/j.cyto.2006.07.015, 16962335.
57. Tso HW, Ip WK, Chong WP, Tam CM, Chiang AK, Lau YL. Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun 2005, 6:358-363. 10.1038/sj.gene.6364189, 15815688.
58. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuber Lung Dis 1998, 79:83-89. 10.1054/tuld.1998.0009, 10645445.
59. Fitness J, Floyd S, Warndorff DK, Sichali L, Malema S, Crampin AC, Fine PE, Hill AV. Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg 2004, 71:341-349.
60. Prabhu AS, Selvaraj P, Jawahar MS, Adhilakshmi AR, Narayanan PR. Interleukin-12B & interleukin-10 gene polymorphisms in pulmonary tuberculosis. Indian J Med Res 2007, 126:135-138.
61. Lopez-Maderuelo D, Arnalich F, Serantes R, Gonzalez A, Codoceo R, Madero R, Vazquez JJ, Montiel C. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 2003, 167:970-975. 10.1164/rccm.200205-438BC, 12531774.
62. Shin HD, Park BL, Kim YH, Cheong HS, Lee IH, Park SK. Common interleukin 10 polymorphism associated with decreased risk of tuberculosis. Exp Mol Med 2005, 37:128-132.
63. Oh JH, Yang CS, Noh YK, Kweon YM, Jung SS, Son JW, Kong SJ, Yoon JU, Lee JS, Kim HJ, Park JK, Jo EK, Song CH. Polymorphisms of interleukin-10 and tumour necrosis factor-alpha genes are associated with newly diagnosed and recurrent pulmonary tuberculosis. Respirology 2007, 12:594-598. 10.1111/j.1440-1843.2007.01108.x, 17587429.
64. Stein CM, Zalwango S, Chiunda AB, Millard C, Leontiev DV, Horvath AL, Cartier KC, Chervenak K, Boom WH, Elston RC, Mugerwa RD, Whalen CC, Iyengar SK. Linkage and association analysis of candidate genes for TB and TNFalpha cytokine expression: evidence for association with IFNGR1, IL-10, and TNF receptor 1 genes. Hum Genet 2007, 121:663-673. 10.1007/s00439-007-0357-8, 17431682.
65. Ates O, Musellim B, Ongen G, Topal-Sarikaya A. Interleukin-10 and tumor necrosis factor-alpha gene polymorphisms in tuberculosis. J Clin Immunol 2008, 28:232-236. 10.1007/s10875-007-9155-2, 18071881.
66. Henao MI, Montes C, Paris SC, Garcia LF. Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. Tuberculosis (Edinburgh, Scotland) 2006, 86:11-19. 10.1016/j.tube.2005.03.001, 15925543.
67. Thye T, Browne EN, Chinbuah MA, Gyapong J, Osei I, Owusu-Dabo E, Brattig NW, Niemann S, Rusch-Gerdes S, Horstmann RD, Meyer CG. IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB. PLoS ONE 2009, 4:e5420. 10.1371/journal.pone.0005420, 2671601, 19412539.
68. Tso HW, Lau YL, Tam CM, Wong HS, Chiang AK. Associations between IL12B Polymorphisms and Tuberculosis in the Hong Kong Chinese Population. J Infect Dis 2004, 190:913-919. 10.1086/422693, 15295696.
69. Davoodi-Semiromi A, Yang JJ, She JX. IL-12p40 is associated with type 1 diabetes in Caucasian-American families. Diabetes 2002, 51:2334-2336. 10.2337/diabetes.51.7.2334, 12086971.
70. Hall MA, McGlinn E, Coakley G, Fisher SA, Boki K, Middleton D, Kaklamani E, Moutsopoulos H, Loughran TP, Ollier WE, Panayi GS, Lanchbury JS. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 2000, 1:219-224. 10.1038/sj.gene.6363661, 11196715.
71. Huang D, Cancilla MR, Morahan G. Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun 2000, 1:515-520. 10.1038/sj.gene.6363720, 11197695.
72. Akahoshi M, Ishihara M, Remus N, Uno K, Miyake K, Hirota T, Nakashima K, Matsuda A, Kanda M, Enomoto T, Ohno S, Nakashima H, Casanova JL, Hopkin JM, Tamari M, Mao XQ, Shirakawa T. Association between IFNA genotype and the risk of sarcoidosis. Hum Genet 2004, 114:503-509. 10.1007/s00439-004-1099-5, 15004750.
73. Morahan G, Kaur G, Singh M, Rapthap CC, Kumar N, Katoch K, Mehra NK, Huang D. Association of variants in the IL12B gene with leprosy and tuberculosis. Tissue Antigens 2007, 69(Suppl 1):234-236. 10.1111/j.1399-0039.2006.773_3.x, 17445208.
74. Freidin MB, Rudko AA, Kolokolova OV, Strelis AK, Puzyrev VP. Association between the 1188 A/C polymorphism in the human IL12B gene and Th1-mediated infectious diseases. Int J Immunogenet 2006, 33:231-232. 10.1111/j.1744-313X.2006.00591.x, 16712658.
75. Ma X, Reich RA, Gonzalez O, Pan X, Fothergill AK, Starke JR, Teeter LD, Musser JM, Graviss EA. No evidence for association between the polymorphism in the 3 ' untranslated region of interleukin-12B and human susceptibility to tuberculosis. Journal of Infectious Diseases 2003, 188:1116-1118. 10.1086/378674, 14551880.
76. Puzyrev VP, Freidin MB, Rudko AA, Strelis AK, Kolokolova OV. [Polymorphisms of the candidate genes for genetic susceptibility to tuberculosis in the Slavic population of Siberia: a pilot study]. Mol Biol (Mosk) 2002, 36:788-791. 10.1023/A:1020611111205, 12391841.
77. Kusuhara K, Yamamoto K, Okada K, Mizuno Y, Hara T. Association of IL12RB1 polymorphisms with susceptibility to and severity of tuberculosis in Japanese: a gene-based association analysis of 21 candidate genes. Int J Immunogenet 2007, 34:35-44. 10.1111/j.1744-313X.2007.00653.x, 17284226.
78. Akahoshi M, Nakashima H, Miyake K, Inoue Y, Shimizu S, Tanaka Y, Okada K, Otsuka T, Harada M. Influence of interleukin-12 receptor beta1 polymorphisms on tuberculosis. Hum Genet 2003, 112:237-243.
79. Remus N, El Baghdadi J, Fieschi C, Feinberg J, Quintin T, Chentoufi M, Schurr E, Benslimane A, Casanova JL, Abel L. Association of IL12RB1 polymorphisms with pulmonary tuberculosis in adults in Morocco. J Infect Dis 2004, 190:580-587. 10.1086/422534, 15243935.
80. Lee HW, Lee HS, Kim DK, Ko DS, Han SK, Shim YS, Yim JJ. Lack of an association between interleukin-12 receptor beta1 polymorphisms and tuberculosis in Koreans. Respiration 2005, 72:365-368. 10.1159/000086249, 16088278.
81. Sahiratmadja E, Baak-Pablo R, de Visser AW, Alisjahbana B, Adnan I, van Crevel R, Marzuki S, van Dissel JT, Ottenhoff TH, Van DV. Association of polymorphisms in IL-12/IFN-gamma pathway genes with susceptibility to pulmonary tuberculosis in Indonesia. Tuberculosis (Edinb) 2007, 87:303-311. 10.1016/j.tube.2007.02.001, 17392024.
82. Ohyama H, Ogata K, Takeuchi K, Namisato M, Fukutomi Y, Nishimura F, Naruishi H, Ohira T, Hashimoto K, Liu T, Suzuki M, Uemura Y, Matsushita S. Polymorphism of the 5' flanking region of the IL-12 receptor beta2 gene partially determines the clinical types of leprosy through impaired transcriptional activity. J Clin Pathol 2005, 58:740-743. 10.1136/jcp.2004.023903, 1770718, 15976343.
83. Lee JS, Song CH, Kim CH, Kong SJ, Shon MH, Kim HJ, Park JK, Paik TH, Jo EK. Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis. Clin Exp Immunol 2002, 128:516-524. 10.1046/j.1365-2249.2002.01858.x, 1906259, 12067307.
84. Dinarello CA, Novick D, Puren AJ, Fantuzzi G, Shapiro L, Muhl H, Yoon DY, Reznikov LL, Kim SH, Rubinstein M. Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol 1998, 63:658-664.
85. Blumenthal A, Ehlers S, Lauber J, Buer J, Lange C, Goldmann T, Heine H, Brandt E, Reiling N. The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 2006, 108:965-973. 10.1182/blood-2005-12-5046, 16601243.
86. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001, 29:306-309. 10.1038/ng749, 11600885.
87. van den Oord EJ. Controlling false discoveries in genetic studies. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:637-644. 10.1002/ajmg.b.30650, 18092307.
88. Gallant CJ, Cobat A, Simkin L, Black GF, Stanley K, Hughes J, Doherty TM, Hanekom WA, Eley B, Beyers N, van Helden P, Abel L, Alcaïs A, Hoal EG, Schurr E. The impact of age and sex on anti-mycobacterial immunity of children and adolescents in an area of high tuberculosis incidence. IJTLD